| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT07357415 A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-09 | NCT07519525 A Study of [14C]-LY4064809 in Healthy Participants |
Trial completed |
| 2026-06-09 | NCT07519525 A Study of [14C]-LY4064809 in Healthy Participants |
Enrollment reduced: 8 -> 7 participants |
| 2026-06-05 | NCT07215559 A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination… |
Trial sites expanded: 38 -> 42 locations |
| 2026-06-05 | NCT07276958 A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus… |
Trial sites reduced: 7 -> 1 locations |
| 2026-06-05 | NCT06657768 A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease… |
Trial sites expanded: 9 -> 13 locations |
| 2026-06-05 | NCT07174336 A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… |
Trial sites expanded: 324 -> 327 locations |
| 2026-06-04 | NCT05784246 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely… |
Trial completed |
| 2026-06-04 | NCT05784246 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely… |
date change Completion moved earlier: 2026-08 -> 2026-05-01 |
| 2026-06-04 | NCT05929066 A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight |
Trial completed |
| 2026-06-04 | NCT06890598 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With… |
Trial sites expanded: 354 -> 361 locations |
| 2026-06-03 | NCT07046923 A Study of LY4175408 in Participants With Advanced Cancer |
Trial arms changed: 3 -> 5 |
| 2026-05-30 | NCT06952530 A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-30 | NCT06948422 A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-30 | NCT06948435 A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT06607185 A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors |
Trial sites reduced: 56 -> 47 locations |
| 2026-05-23 | NCT07232732 A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-23 | NCT06635057 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan |
Trial completed |
| 2026-05-23 | NCT06635057 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan |
Enrollment increased: 130 -> 166 participants |
| 2026-05-23 | NCT06238479 A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors |
date change Completion pushed: 2027-03 -> 2027-04 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07641504 A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic… | Phase 2 | Not Yet Recruiting |
| 2026-06-11 | NCT07641517 A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With… | Phase 2 | Not Yet Recruiting |
| 2026-06-05 | NCT07629401 Provide Pre-approval Expanded Access of LY3437943 | Available | |
| 2026-05-29 | NCT07613294 A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With… | Phase 3 | Not Yet Recruiting |
| 2026-05-29 | NCT07613307 A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe… | Phase 3 | Not Yet Recruiting |
| 2026-05-28 | NCT07612267 A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving… | Phase 4 | Not Yet Recruiting |
| 2026-05-26 | NCT07607483 A Study of LY4065967 in Healthy Participants | Phase 1 | Not Yet Recruiting |
| 2026-05-22 | NCT07602582 A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM… | Phase 3 | Not Yet Recruiting |
| 2026-05-20 | NCT07598370 A Study of LY3439539 in Participants With Alzheimer's Disease | Phase 1 | Not Yet Recruiting |
| 2026-05-18 | NCT07592572 A Study of the Effects of Itraconazole on LY4395089 in Healthy Participants | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06876649 | A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06876662 | A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07247084 | A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants… | Obesity | Recruiting |
| NCT07438444 | A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2… | Diabetes Mellitus, Type 2 | Recruiting |
| NCT07218341 | A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT06857942 | A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation… | Psoriasis | Recruiting |
| NCT06864026 | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in… | Psoriatic Arthritis | Recruiting |
| NCT07006792 | A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic… | Atopic Dermatitis | Active, Not Recruiting |
| NCT07612267 | A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving… | Lactation | Not Yet Recruiting |
| Phase 3 | |||
| NCT04088396 | A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old… | Systemic Juvenile Idiopathic Arthritis | Recruiting |
| NCT06339008 | A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis… | Perennial Allergic Rhinitis (PAR) | Recruiting |
| NCT03773965 | A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With… | Juvenile Idiopathic Arthritis | Recruiting |
| NCT06739122 | A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type… | Type 2 Diabetes | Recruiting |
| NCT07142954 | Epidemiology and Biomarker Study in Alzheimer's Disease | Alzheimer Disease | Recruiting |
| NCT06672549 | A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) | Obesity | Recruiting |
| NCT05723198 | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age… | Areata Alopecia | Recruiting |
| NCT07035093 | A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and… | Obesity | Recruiting |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease | Crohn's Disease | Recruiting |
| NCT07213804 | A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With… | Ovarian Neoplasms | Recruiting |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants… | Ulcerative Colitis | Recruiting |
| NCT06119581 | A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT06338995 | A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal… | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Recruiting |
| NCT06439277 | A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities… | Obesity | Recruiting |
| NCT06672939 | A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or… | Obesity | Recruiting |
| NCT06890598 | Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With… | Carcinoma, Non-Small-Cell Lung | Recruiting |